[The entry of Epstein-Barr virus into B lymphocytes and epithelial cells during infection]
- PMID: 25272606
[The entry of Epstein-Barr virus into B lymphocytes and epithelial cells during infection]
Abstract
Epstein-Barr virus (EBV) is a human herpesvirus associated with important human diseases, including infectious mononucleosis syndrome, malignant lymphoma, and nasopharyngeal carcinoma. The mechanism of EBV entry into host cells remains a subject of intensive research. After decades of study, researchers have identified several key proteins and different patterns of EBV intrusion into host cells. The viral surface glycoproteins, gp350/220, gp42, gB, gH, and gL, are involved in interactions with the CR2 receptor on the surface of B lymphocytes during viral entry. However, the majority of epithelial cells lack CR2 receptor expression, which makes viral invasion much more complex than in B lymphocytes. Three different models have been proposed to explain how EBV enters epithelial cells: (1) "transfer of infection", mediated by B lymphocytes or Langerhans cells; (2) EBV utilizes its own proteins during the process of fusion with the cell membrane; and (3) progeny virions arising from EBV-infected epithelial cells cross lateral membranes into adjacent epithelial cells. This review will discuss the relevant mechanism of viral entry into B lymphocytes and epithelial cells during EBV infection.
Similar articles
-
Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.J Virol. 2007 Sep;81(17):9216-29. doi: 10.1128/JVI.00575-07. Epub 2007 Jun 20. J Virol. 2007. PMID: 17581996 Free PMC article.
-
Membrane anchoring of Epstein-Barr virus gp42 inhibits fusion with B cells even with increased flexibility allowed by engineered spacers.mBio. 2015 Jan 6;6(1):e02285-14. doi: 10.1128/mBio.02285-14. mBio. 2015. PMID: 25564465 Free PMC article.
-
The Cytoplasmic Tail Domain of Epstein-Barr Virus gH Regulates Membrane Fusion Activity through Altering gH Binding to gp42 and Epithelial Cell Attachment.mBio. 2016 Nov 15;7(6):e01871-16. doi: 10.1128/mBio.01871-16. mBio. 2016. PMID: 27935841 Free PMC article.
-
Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.Mol Cells. 2016 Apr 30;39(4):286-91. doi: 10.14348/molcells.2016.0066. Epub 2016 Apr 6. Mol Cells. 2016. PMID: 27094060 Free PMC article. Review.
-
Viral Entry.Curr Top Microbiol Immunol. 2015;391:221-35. doi: 10.1007/978-3-319-22834-1_7. Curr Top Microbiol Immunol. 2015. PMID: 26428376 Review.
Cited by
-
GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection.Arch Virol. 2024 Jul 17;169(8):167. doi: 10.1007/s00705-024-06095-3. Arch Virol. 2024. PMID: 39020055 Review.
-
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma.Front Immunol. 2023 Jan 11;13:1079515. doi: 10.3389/fimmu.2022.1079515. eCollection 2022. Front Immunol. 2023. PMID: 36713430 Free PMC article. Review.